See how many lives could have been saved with COVID vaccinations in each state. An analysis by Brown University and Microsoft AI Health estimated the portion of vaccine-preventable deaths in each state since the start of 2021. (NPR)
Baby formula shortages: bad for parents but good for Abbott Laboratories stock? The scarcity of baby formula, which has even attracted attention from the White House, could be a boon for the company’s stock, which is down more than 23% year to date. (Barron’s)
Novavax said it’s confident the Food and Drug Administration will authorize COVID vaccine in June. If the FDA panel endorses the shot in June, the drug regulator is almost certain to rapidly authorize the two-dose regimen for use in the U.S. (CNBC)
Business incentives aligned with social impact could change legal cannabis. “Despite its comparatively small size, the cannabis industry has the potential to disrupt mainstream pharma by offering alternatives to pharmaceutical,” writes Jeffrey Zucker, president of Green Lion Partners. (Rolling Stone)
Clearmind Medicine to meet with the Center for Drug Evaluation and Research about a psychedelics-based drug that can treat alcoholism. CMND-100, the company’s flagship product, reportedly produces a reduction in the desire of consuming alcohol. (Benzinga)
